N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
US-9221780-B2 · Dec 29, 2015 · US
US9540329B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9540329-B2 |
| Application number | US-201213553495-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 19, 2012 |
| Priority date | Jul 19, 2012 |
| Publication date | Jan 10, 2017 |
| Grant date | Jan 10, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Heteroleptic complexes having at least one diarylamino or carbazole group, as shown in Formula (I), are provided: wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 each represent mono, di, tri, tetra, or penta substitutions or no substitution; wherein Z is a single bond connecting the two phenyl rings, or is absent, wherein when Z is absent, the positions on the phenyl rings may be substituted by R 5 or R 6 ; wherein any two adjacent substituents are optionally joined together to form a ring, which may be further substituted; wherein each of R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 is independently selected from various substituents; and wherein m is 1 or 2. Devices, such as organic light emitting devices (OLEDs) that comprise phosphorescent light emitting materials are also provided.
Opening claim text (preview).
The invention claimed is: 1. A first device comprising a first organic light emitting device, the first organic light emitting device further comprising: an anode; a cathode; and an organic layer, disposed between the anode and the cathode, comprising a heteroleptic metal complex of Formula (V): wherein R 1 , R 2 , R 3 , and R 4 each represent mono, di, tri, tetra, or penta substitutions or no substitution; wherein R 5 and R 6 represent no substitutions; wherein any two adjacent substituents are optionally joined together to form a ring, which may be further substituted; wherein each of R 1 , R 2 , R 3 , and R 4 is independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof; and wherein m is 1 or 2. 2. The first device of claim 1 , wherein the heteroleptic metal complex is a compound of Formula (VI): 3. The first device of claim 1 , wherein m is 1. 4. The first device of claim 1 , wherein m is 2. 5. The first device of claim 1 , wherein the heteroleptic metal complex is selected from the group consisting of: 6. The first device of claim 1 , wherein the heteroleptic metal complex is selected from the group consisting of: 7. The first device of claim 1 , wherein each of R 1 , R 2 , R 3 , and R 4 is selected from the group consisting of: hydrogen, deuterium, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, and partially or fully deuterated variations thereof. 8. The first device of claim 1 , wherein each of R 1 , R 2 , R 3 , and R 4 is selected from the group consisting of: hydrogen, deuterium, alkyl, and combinations thereof. 9. The first device of claim 1 , wherein each of R 1 , R 2 , R 3 , and R 4 is selected from the group consisting of: hydrogen, deuterium, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, cyclopentyl, cyclohexyl, and combinations thereof. 10. The first device of claim 1 , wherein the first device is a consumer product. 11. The first device of claim 1 , wherein the first device is an organic light-emitting device. 12. The first device of claim 1 , wherein the first device comprises a lighting panel. 13. The first device of claim 1 , wherein the organic layer is an emissive layer and the complex is an emissive dopant. 14. The first device of claim 1 , wherein the organic layer is an emissive layer and the complex is a non-emissive dopant. 15. The first device of claim 1 , wherein the organic layer further comprises a host. 16. The first device of claim 15 , wherein the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan; wherein any substituent in the host is an unfused substituent independently selected from the group consisting of C n H 2n+1 , OC n H 2n+1 , OAr 1 , N(C n H 2n+1 ) 2 , N(Ar 1 )(Ar 2 ), CH═CH—C n H 2n+1 , C≡CC n H 2n+1 , Ar 1 , Ar 1 -Ar 2 , and C n H 2n —Ar 1 ; wherein n is from 1 to 10; and wherein Ar 1 and Ar 2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. 17. The first device of claim 15 , wherein the host is selected from the group consisting of: and combinations thereof. 18. The first device of claim 15 , wherein the host comprises a metal complex.
bridged by heteroatoms, e.g. N, P, Si or B · CPC title
Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals · CPC title
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
Condensed systems · CPC title
Apparatus or processes specially adapted to the manufacture of electroluminescent light sources · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.